Ming Tan

17.6k citations
226 papers · 14.0k · 5 hit papers · h-index 58

Impact in

    • Cancer, Hypoxia, and Metabolism
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research

Papers in

    • RNA modifications and cancer 12
    • Metabolism, Diabetes, and Cancer 8
    • Cancer, Hypoxia, and Metabolism 21
    • MicroRNA in disease regulation 18
    • Cancer-related molecular mechanisms research 15

Ming Tan

219 papers receiving 13.7k citations

Ming Tan's Hit Papers

The role of ChatGPT in scientific communication: writing better scientific review articles. 2023 · 217 citations
2170+7+14Years since publication4008001.2k

Peers

Ming Tan
Comparison fields: 5 of 183
  • Cancer Research 3.9k
  • Oncology 3.9k
  • Health Informatics 145
  • Molecular Biology 6.8k
  • Immunology 1.3k
Replace Rui‐Hua Xu with:
Rui‐Hua Xu China
Emile E. Voest Netherlands
James D. Brooks United States
Jorma Isola Finland
Vijay H. Shah United States
Erwin P. Böttinger United States
George Wilding United States
George M. Yousef Canada
Stephen J. Pandol United States
Fátima Cardoso Portugal
Ming Tan relative to Rui‐Hua Xu China Rui‐Hua Xu's profile →
Citations per field
00.5×1.5×2.1×
Rui‐Hua Xu · 1×
Citations per year

Countries citing papers authored by Ming Tan

Since Specialization
Citations

This map shows the geographic impact of Ming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Tan more than expected).

Fields of papers citing papers by Ming Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Tan. The network helps show where Ming Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming Tan Line = papers co-authored together Ming Tan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Hit paper breakdown →
20041469
2
Targeting cellular metabolism to improve cancer therapeutics
Hit paper breakdown →
2013840
3
The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism
Hit paper breakdown →
2014624
4 2004453
5 1996411
6 2010366
7 2018349
8 2010332
9 1998312
10 2004263
11 2011245
12 2011230
13 2009223
14
The role of ChatGPT in scientific communication: writing better scientific review articles.
Hit paper breakdown →
2023217
15 2017214
16 2011203
17
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
1997196
18 2012190
19
Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
1996189
20 2017166

About Ming Tan

Ming Tan is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Immunology, having authored 226 papers that have together received 14.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (21 papers), MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (15 papers), HER2/EGFR in Cancer Research (13 papers), Cancer-related Molecular Pathways (13 papers), RNA modifications and cancer (12 papers), Autophagy in Disease and Therapy (10 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Cancer Research (3.9k citations), Oncology (3.9k citations), Health Informatics (145 citations), Molecular Biology (6.8k citations) and Immunology (1.3k citations). Ming Tan has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include Dihua Yu, Jianrong Lu, Ethan B. Butler, Yinglan Zhao, Mien‐Chie Hung, Qingsong Cai, Øystein Fodstad, Xiaoyan Zhou, Keng‐Hsueh Lan and Kristine S. Klos. Their work appears in journals such as Cancer Research, PLoS ONE, Cell Death and Disease, Oncotarget and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact